Dashboard
Weak Long Term Fundamental Strength with a -10.08% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.80 times
- The company has been able to generate a Return on Equity (avg) of 6.32% signifying low profitability per unit of shareholders funds
Stock is technically in a Mildly Bearish range
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 330 Cr (Micro Cap)
27.00
42
0.26%
0.49
6.34%
1.35
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Sep-16-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Aarti Surfactants Ltd Valuation Shifts Highlight Price Attractiveness Amid Market Challenges
Aarti Surfactants Ltd, a micro-cap player in the Specialty Chemicals sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite recent share price declines and a challenging market environment, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for investors seeking value in a volatile sector.
Read More
Aarti Surfactants Ltd Valuation Shifts Signal Changing Market Sentiment
Aarti Surfactants Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its valuation parameters, moving from a 'very attractive' to an 'attractive' rating. This change comes amid a sharp 10.85% decline in its share price on 12 May 2026, reflecting broader market pressures and evolving investor sentiment. An in-depth analysis of its price-to-earnings (P/E), price-to-book value (P/BV), and other key financial metrics reveals the nuances behind this valuation adjustment and its implications for investors.
Read More
Aarti Surfactants Ltd Downgraded to Sell as Quality Metrics Deteriorate
Aarti Surfactants Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its quality grading downgraded from average to below average, reflecting a marked deterioration in key business fundamentals. The company’s financial metrics, including return on equity (ROE), return on capital employed (ROCE), and debt levels, have shown concerning trends that have prompted a sell rating with a Mojo Score of 34.0 as of 8 April 2026.
Read More Announcements 
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015
15-Jun-2026 | Source : BSEDisclosure under Regulation 30 of the SEBI (LODR) Regulations 2015
Compliances-Reg.24(A)-Annual Secretarial Compliance
19-May-2026 | Source : BSEAnnual Secretarial Compliance Report for the year ended March 31 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
11-May-2026 | Source : BSENewspaper Publication of Financial Results.
Corporate Actions 
No Upcoming Board Meetings
Aarti Surfactants Ltd has declared 10% dividend, ex-date: 16 Sep 25
No Splits history available
No Bonus history available
Aarti Surfactants Ltd has announced 2:17 rights issue, ex-date: 17 Jan 23
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 2 FIIs (0.14%)
Nikhil Holdings Private Limited (14.86%)
Padmika Projects Llp (1.56%)
42.18%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 23.34% vs 15.97% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 14.48% vs 134.62% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 34.26% vs 0.58% in Sep 2024
Growth in half year ended Sep 2025 is 11.66% vs -59.66% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 31.91% vs 5.96% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 68.94% vs -71.03% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 30.35% vs 11.74% in Mar 2025
YoY Growth in year ended Mar 2026 is -15.13% vs -31.83% in Mar 2025